Mrv0541 02231216532D 17 18 0 0 1 0 999 V2000 0.7145 -0.4125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.7145 -1.2375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.3819 -1.7224 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 1.1270 -2.5070 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 0.3020 -2.5070 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.0470 -1.7224 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -0.1830 -3.1745 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 0.1526 -3.9282 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -0.3323 -4.5956 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 0.0032 -5.3493 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.8237 -5.4355 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -1.1528 -4.5094 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 -1.6377 -5.1768 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -1.4884 -3.7557 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 -2.3088 -3.6695 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -1.0034 -3.0882 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 -1.3390 -2.3346 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 1 2 1 0 0 0 0 2 3 2 0 0 0 0 3 4 1 0 0 0 0 4 5 2 0 0 0 0 5 6 1 0 0 0 0 2 6 1 0 0 0 0 7 5 1 1 0 0 0 7 8 1 0 0 0 0 8 9 1 0 0 0 0 9 10 1 1 0 0 0 10 11 1 0 0 0 0 9 12 1 0 0 0 0 12 13 1 6 0 0 0 12 14 1 0 0 0 0 14 15 1 1 0 0 0 14 16 1 0 0 0 0 7 16 1 0 0 0 0 16 17 1 6 0 0 0 M END > DB03354 > drugbank > CC1=NN=C(O1)[C@H]1O[C@@H](CO)[C@H](O)[C@@H](O)[C@@H]1O > InChI=1S/C9H14N2O6/c1-3-10-11-9(16-3)8-7(15)6(14)5(13)4(2-12)17-8/h4-8,12-15H,2H2,1H3/t4-,5-,6+,7-,8-/m0/s1 > InChIKey=HCSFWJQLIPWUFZ-RLMOJYMMSA-N > 7 > 23.33690447749918 > 1 > 4 > 246.08518619 > 0 > C9H14N2O6 > 0 > (2S,3R,4R,5S,6S)-2-(hydroxymethyl)-6-(5-methyl-1,3,4-oxadiazol-2-yl)oxane-3,4,5-triol > -1.62 > -3.4542149643333335 > -0.70 > 246.2173 > 0 > 2 > 0 > 13.29580628995572 > 12.399714301764586 > -1.6979927395599526 > 129.07000000000002 > 53.9447 > 2 > 1 > 4.87e+01 g/l > (2S,3R,4R,5S,6S)-2-(hydroxymethyl)-6-(5-methyl-1,3,4-oxadiazol-2-yl)oxane-3,4,5-triol > 0 > DB03354 > experimental > 2-(Beta-D-Glucopyranosyl)-5-Methyl-1,3,4-Oxadiazole $$$$